Apraclonidine Hydrochloride

CHEMBL1200379 Phase 4 承認済み Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

281.6 g/mol

LogP

—

Phase

4

The hydrochloride salt of apraclonidine, an ophthalmic agent that lowers eye pressure by activating alpha-2 receptors to decrease fluid production inside the eye. It is used in the short-term management of glaucoma and after certain eye procedures.

分子量

281.6000 g/mol

TPSA

62.40 Å²

治療領域

Glaucoma Hypertension

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D構造

SVG PNG

Cite this structure

Embed this structure

SMILES

Cl.Nc1cc(Cl)c(N=C2NCCN2)c(Cl)c1

InChI

InChI=1S/C9H10Cl2N4.ClH/c10-6-3-5(12)4-7(11)8(6)15-9-13-1-2-14-9;/h3-4H,1-2,12H2,(H2,13,14,15);1H

Molecular Formula

C9H11Cl3N4

HBD / HBA

4 / 2

回転可能結合数

2

重原子数

16

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

よくある質問

The hydrochloride salt of apraclonidine, an ophthalmic agent that lowers eye pressure by activating alpha-2 receptors to decrease fluid production inside the eye. It is used in the short-term management of glaucoma and after certain eye procedures.

Yes, Apraclonidine Hydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200379. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 51763. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

患者向けのわかりやすい情報をお探しですか？

Apraclonidine Hydrochloride PillFYIで

構造

クイックデータ

分子式: C9H11Cl3N4
同義語: 3

外部リンク

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

医学的免責事項

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.